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Joubert syndrome and related disorders (JSRD) are primarily autosomal-recessive conditions characterized by hypotonia, ataxia, abnor-
mal eye movements, and intellectual disability with a distinctive mid-hindbrain malformation. Variable features include retinal dystro-
phy, cystic kidney disease, and liver ﬁbrosis. JSRD are included in the rapidly expanding group of disorders called ciliopathies, because all
six gene products implicated in JSRD (NPHP1, AHI1, CEP290, RPGRIP1L, TMEM67, and ARL13B) function in the primary cilium/basal
body organelle. By using homozygosity mapping in consanguineous families, we identify loss-of-function mutations in CC2D2A in
JSRD patients with and without retinal, kidney, and liver disease. CC2D2A is expressed in all fetal and adult tissues tested. In ciliated
cells, we observe localization of recombinant CC2D2A at the basal body and colocalization with CEP290, whose cognate gene is mutated
in multiple hereditary ciliopathies. In addition, the proteins can physically interact in vitro, as shown by yeast two-hybrid and GST pull-
down experiments. A nonsense mutation in the zebraﬁsh CC2D2A ortholog (sentinel) results in pronephric cysts, a hallmark of ciliary
dysfunction analogous to human cystic kidney disease. Knockdown of cep290 function in sentinel ﬁsh results in a synergistic pronephric
cyst phenotype, revealing a genetic interaction between CC2D2A and CEP290 and implicating CC2D2A in cilium/basal body function.
These observations extend the genetic spectrum of JSRD and provide amodel system for studying extragenicmodiﬁers in JSRD and other
ciliopathies.Introduction
Joubert syndrome and related disorders (JSRD [MIM
213300]) encompass a group of conditions characterized
by hypotonia, ataxia, abnormal eye movements, and intel-
lectual disability with amid-hindbrain brainmalformation
giving the appearance of a molar tooth on brain imaging
(themolar tooth sign [MTS]).1Other,more variable, clinical
features include retinal dystrophy, coloboma, polydactyly,
cystic renal disease, hepatic ﬁbrosis, and other brainmalfor-
mations that have been used to deﬁne clinical subtypes of
JSRD such as COACH (cerebellar vermis hypoplasia, oligo-
phrenia, ataxia, coloboma, and hepatic ﬁbrosis [MIM
216360]).2 Thus far, mutations in six genes (NPHP1 [MIMThe America607100], AHI1 [MIM 608894], CEP290 [MIM 610142],
RPGRIP1L [MIM 610937], TMEM67 [MIM 609884], and
ARL13B [MIM 608922]) have been identiﬁed in patients
with JSRDandall of thegeneproductshavebeen implicated
in the function of the primary cilium/basal body.1,3–13 JSRD
are therefore included in the expanding group of disorders
resulting from ciliary dysfunction, including Meckel syn-
drome (MKS [MIM 249000]), Bardet-Biedl syndrome (BBS
[MIM 209900]), nephronophthisis (MIM 256100), and
Leber congenital amaurosis (LCA [MIM 204000]). These
disorders, termed ciliopathies,14 share both phenotypic
features (retinal dystrophy,polydactyly, cystic renaldisease,
and hepatic ﬁbrosis) and molecular causes.14,15 For exam-
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basal bodyproteinCEP290 cause a spectrumof overlapping
phenotypes including JSRD,MKS, LCA, andBBS, and loss of
CEP290 function causes cilium defects in mammalian
cells.5,16–20 The human phenotypes, including kidney
cysts, are partially recapitulated in a zebraﬁsh model for
loss of CEP290 function.5
In this work, we report mutations in the CC2D2A gene
(MIM 612013) as a cause of JSRD in a substantial subset of
a large, unselected JSRD cohort, including mutations
associated with the distinctive COACH subtype. CC2D2A
encodes a coiled-coil andC2domainproteinwithpredicted
structural similarity to RPGRIP1 (MIM 605446) and
RPGRIP1L, proteins known to be involved in LCA and
JSRD/MKS, respectively;3,4,21 however, little is knownabout
the function of these proteins. Recently, CC2D2A muta-
tions have been associated with autosomal-recessive men-
tal retardation with retinitis pigmentosa (now known to
be Joubert syndrome) and MKS.22,23 In addition, we show
that loss ofCC2D2A function in the zebraﬁshmutant senti-
nel leads to thedevelopmentof pronephric cysts, ahallmark
of cilium dysfunction. Further, we show that CC2D2A co-
localizes at the basal bodies of cilia and physically interacts
withCEP290. This interaction is likely to be physiologically
relevant, because suppression of cep290 function in zebra-
ﬁsh signiﬁcantly enhances the pronephric cyst phenotype
of the sentinel mutant. This work extends the phenotypic
spectrum caused by CC2D2A mutations to include JSRD
and indicates that CC2D2A functions with CEP290 in the
primary cilium/basal body protein network.
Material and Methods
Subjects
Subjects were recruited worldwide and collected under the
approval of the Human Subjects Divisions at the University of
Washington, the University of Michigan, and Johns Hopkins
University. Characteristic brain-imaging ﬁndings, combined
with developmental delay and ataxia, were the minimal criteria
for JSRD, whereas subjects with BBS were ascertained as described
by Beales et al.24 Cerebellar vermis hypoplasia was a sufﬁcient im-
aging criterion in subjects not evaluated byMRI. Known genes and
loci for JSRD (AHI1, CEP290, NPHP1, TMEM67, chromosomal loci
9q34, and 11p11.2–q12.1) were excluded in the consanguineous
families by either haplotype analysis for homozygosity via micro-
satellite markers or by direct sequencing. Nonconsanguineous
families with mutations in NPHP1 and AHI1 were also excluded
from the analysis.
SNP and Microsatellite Marker Genotyping
Single nucleotide polymorphisms (SNPs) were genotyped with the
GeneChip Human Mapping 50K Array Xba 240 (Affymetrix Inc.,
Santa Clara, CA) under standard conditions. The arrays were
scanned with a GeneChip Scanner 3000 and calls were assigned
with GeneChip Operating Software (GCOS) and Genotyping
Analysis Software. Overlapping homozygous intervals were identi-
ﬁed with Excel (Microsoft Corporation, Redmond,WA) and shared
haplotypes were identiﬁed with Stata Corp. (College Station, TX;
code available on request). Microsatellite markers on chromosome560 The American Journal of Human Genetics 83, 559–571, Novem4p15 were genotyped with ABI primers and an ABI PRISM 3100
Genetic Analyzer (Applied Biosystems, Austin, TX).
DNA Sequencing
Sequencing was performed according to the manufacturer’s in-
structions with Big Dye terminator version 3.1 and an ABI PRISM
3100 Genetic Analyzer (Applied Biosystems). Forward and reverse
strands of all 38 CC2D2A exons were sequenced, as well as ~30 bp
of ﬂanking intronic sequence. Primers and conditions used are
depicted in Table S1 available online.
Sequence Analysis
Alignments were performed with Clustal W2 and Boxshade 3.21.
Homology calculations were performed with Vector NTI10
(Invitrogen Corporation, Carlsbad, CA). Phylogenetic trees were
constructed with BLAST and TreeFam.
RT-PCR for Human Transcripts
Fetal eye and liver mRNA was isolated with the RNeasy Mini Kit
(QIAgen, Valencia, CA) and all other RNAs were purchased: adult
retina from Clontech (Mountain View, CA), adult brain, kidney,
liver, heart, lung, and skeletal muscle from Ambion (Austin, TX),
and fetal brain and kidney from Virogen (Watertown, MA).
RT-PCR analysis of CC2D2A, CC2D2B, RPGRIP1L, and HPRT (con-
trol) was performed on total RNA from adult brain, retina, heart,
kidney, liver, and skeletal muscle, as well as 12–16 week human
fetal brain, eye, kidney, and liver. The primers are depicted in Table
S1. Ampliﬁcationwas carried out in PCR buffer containing 2.5mM
MgCl2 (32 cycles of denaturation for 30 s at 94
C, annealing for
30 s at 55C [50C for RPGRIP1L], and extension for 1 min at
72C, with an initial denaturation step for 4 min at 94C). The
number of cycles was titrated so that the amount of product was
not saturated in any tissue.
Immunocytochemistry
hTERT-RPE1 cells (kindly provided byUweWolfrum)were cultured
as described previously19 and stained with anti-CEP290 (rabbit
polyclonal, kindly provided by ErichNigg) 1:100 orGT-335 (mouse
monoclonal, kindly provided by Carsten Janke) 1:1000. hTERT-
RPE1 cells were seeded on glass slides, grown overnight, and then
transfected for 24 hr with eCFP-CC2D2Awith Effectene (QIAgen),
according to manufacturer’s instructions. Primary cilium forma-
tion in hTERT-RPE1 cells was induced by serum starvation (0.2%
serum) for another24hr. Prior toﬁxation, ciliatedhTERT-RPE1 cells
were washed brieﬂy in PBS, ﬁxed in ice-cold methanol for 10 min,
and blocked with 2% BSA in PBS for 20 min. Slides were incubated
with the primary antibodies for 1 hr at room temperature and
subsequently washed with PBS. Subsequently, slides were incu-
bated with secondary antibodies that were described previously.
Washing with PBS was repeated. Cells were then embedded in
Vectashield with DAPI (Vector Laboratories, Burlingame, CA) and
analyzed with a Zeiss Axio Imager Z1 ﬂuorescence microscope
equipped with a 633 objective lens (Carl Zeiss, Sliedrecht, The
Netherlands). Optical sections were generated through structured
illumination by inserting an ApoTome slider into the illumination
path, followed by processing with AxioVision (Carl Zeiss) and
Photoshop CS2 software (Adobe Systems, San Jose, CA).
Yeast Two-Hybrid
Fragments of CC2D2A were tested for binding with proteins
associated with ciliary disorders or cilia function (Table S2). Theber 7, 2008
N-terminal region until the C2 domain (1–998 aa), the C2 domain
with the remaining C-terminal part (992–1561 aa), and the C2
domain alone (992–1177 aa) were cloned in pAD as well as pBD
Gateway-adapted vectors. Yeast two-hybrid screening with ciliary
proteins was performed in both directions. The BD Yeastmaker kit
(Clontech)wasused for transformationof yeast strains PJ69-4alpha
and PJ69-4A with pBD and pAD vectors, respectively, according to
the manufacturer’s protocol. Yeast strains were mated and cotrans-
formed yeast colonies were selected on plates lacking leucine (-L)
and tryptophan (-W). Activation of the reporter geneswas detected
on selection plates lacking histidine (-LWH) and adenine (-LWHA).
In addition, X-b-gal colorimetric ﬁlter lift assays (LacZ reporter
gene) were performed to conﬁrm the interaction as described.3
GST Pull-Down
We cloned the part of CEP290 (coiled-coil domain 4-6 encoded by
amino acid residues 703–1030) that interacts with CC2D2A by
yeast two-hybrid experiments with pDEST15, and we transformed
this plasmid inBL21-DE3 cells. IPTG (Sigma-Aldrich, St. Louis,MO)
was used to induce the expression of N-terminally GST-tagged
CEP290 or GST alone. Puriﬁcation of GST-CEP290cc4-6 (~78 kDa)
or GST alone (~26 kDa) was performed as described.3 Bacterial ly-
sateswere added to50ml of glutathioneSepharose4Bcoupledbeads
(Amersham Biosciences, Piscataway, NJ). Beads were washed twice
with 13 STE (10mMTris-HCl [pH8.0]; 1mMEDTA; 150mMNaCl)
and incubated for 2 hr. Beads were again washed twice and incu-
bated for 2 hr with lysates of COS-1 cells expressing a Flag-tagged
fragment of CC2D2A (amino acids 1–998 encoding the N-terminal
part until the C2 domain), followed by ﬁve washes with Triton-X
buffer (50 mM Tris-HCl [pH 7.5]; 150 mM NaCl; 0.5% Triton
X-100). Finally, we added Laemmli Sample Buffer (Bio-Rad Labora-
tories, Hercules, CA) to the beads and performed western blotting
withmouse anti-Flag (1:1000, cloneM2; Sigma-Aldrich), secondary
IRDye800 goat anti-mouse antibody (1:20,000; Rockland) and the
ODYSSEY system (Li-Cor, Lincoln, NE), as described.3
RT-PCR Methods for Zebraﬁsh Transcripts
All zebraﬁsh work was performed under an approved protocol at
the Fred Hutchinson Cancer Research Center. At 48 hpf, 40 snl/
snl zebraﬁshwere identiﬁed by the sinusoidal tail phenotype. Like-
wise, 40 snl/þ andþ/þﬁsh fromthe samecrosswerepooled.Whole
zebraﬁsh embryos were homogenized by mortar and pestle and
passed throughQIAshredder columns (QIAgen). Total RNAwas iso-
lated from the homogenate with the RNeasy Mini Kit (QIAgen).
cDNAwas reverse transcribed from total RNAwith randomprimers
and reagents supplied in theRETROscript Kit (Ambion). Primers for
sentinel and the odc1 (ornithine decarboxylase 1) housekeeping
control gene are depicted in Table S1. Ampliﬁcation was carried
out for 34 cycles.
Genotyping for ZF
dCAP primers at the site of the sentinel mutation were designed
to create an EcoRV restriction enzyme site in the PCR product
from wild-type ﬁsh. Zebraﬁsh genomic DNA was isolated with
standard techniques. We used an annealing temperature of 64C
for 35 ampliﬁcation cycles. Digested fragments were analyzed on
2% agarose gels.
Antibody Staining
Zebraﬁsh embryos were ﬁxed in Dent’s ﬁx (80% methanol/20%
DMSO) at 4C overnight. After gradual rehydration, they wereThe Americawashed several times in PBST (13 PBS with 0.5% Tween20) and
blocked in PBS-DBT (1% DMSO/1% BSA/0.5% Tween20) with
10% normal sheep serum (NSS) (Sigma-Aldrich) at room tempera-
ture for 2 hr. Primary antibody incubation in PBS-DBT 10% NSS
(1:2000 monoclonal anti-acetylated tubulin 6-11B-1 [Sigma-
Aldrich]) was at 4C overnight. Embryos were washed in PBST
and blocked in PBS-DBT 10% NSS at RT for 1 hr and then incu-
bated in 1:1000 goat anti-mouse Alexa Fluor 488 (Invitrogen) in
PBS-DBT 10% NSS at 4C overnight. After rinsing in PBS, the
embryos were washed with methanol and equilibrated in clearing
solution (1/3 benzoyl-alcohol and 2/3 benzoyl-benzoate) and
examined with a Zeiss LSM510 confocal microscope.
Morpholino Injections
Antisense morpholino oligonucleotides blocking the function of
CEP2905 were obtained fromGeneTools (Corvalis, OR). Morpholi-
nos were diluted to a working concentration of 5 ng/nl in 0.2 M
KCl, and 4 nl were pressure-injected into one- or two-cell stage
zygotes.
Results
Homozygosity Mapping
To identify candidate loci for JSRD, we performed homozy-
gosity mapping in consanguineous families with JSRD as
described by Lander and Botstein.25 The JSRD diagnosis
was established by the presence of the MTS on brain MRI
(Figures 1A–1E) and/or vermis hypoplasia on CT scan
with supportive clinical ﬁndings: developmental delay/
intellectual disability, ataxia, and/or abnormal eye move-
ments. We genotyped affected and unaffected siblings in
28 consanguineous families with JSRD from multiple
ethnic groups, with a cutoff of 80 consecutive homozygous
SNPs to identify candidate regions of homozygosity in
affected offspring of parents separated by six to nine meio-
ses. Regions of homozygosity shared by affected and
unaffected siblings were excluded. To further narrow these
candidate regions, we also identiﬁed shared haplotypes
of homozygous SNPs within and across families (Figures
1F–1H).
In Levanten Arab family UW50, we identiﬁed a shared
haplotype of 252 consecutive homozygous SNPs spanning
7.6 Mb on chromosome 4p15 in two cousins, consistent
with inheritance from a common ancestor (Figure 1F).
These cousins shared no other regions of homozygosity
greater than 50 consecutive homozygous SNPs, and the
shared haplotype was heterozygous in available family
members predicted to be obligate carriers. In Saudi Arabian
families UW36 and UW48, the affected individuals shared
a distinct haplotype of 64 consecutive homozygous SNPs
at 4p15, providing additional evidence for a JSRD gene at
this locus and narrowing the interval to 2.3Mb (Figure 1G).
The affected individuals did not share any other homozy-
gous haplotypes greater than 38 consecutive SNPs. A
fourth family (UW41) also had a large homozygous inter-
val at chromosome 4p15 (Figure 1H). Segregation of the
shared haplotype in each family was consistent with
autosomal-recessive inheritance.n Journal of Human Genetics 83, 559–571, November 7, 2008 561
Figure 1. Homozygosity Mapping in Consanguineous Families with Joubert Syndrome
(A and B) Sagittal (A) and axial (B) MRI images of subject UW50 VI:3 revealing cerebellar vermis hypoplasia (arrowhead) and thick
horizontally oriented superior cerebellar peduncles (arrow). (A) T2-weighted image; (B) T1-weighted image.
(C–E) Sagittal (C) and axial (D, E) MRI images of subject UW50 VI:1 revealing findings similar to subject UW50 VI:3. The midline tissue on
the sagittal views (plus signs) is cerebellar hemisphere rather than vermis. Note the lack of corpus callosum (asterisk in [C]) and colpo-
cephalic configuration of the lateral ventricles (brackets in [E]). T1-weighted images.
(F and G) Haplotypes at chromosome 4p15 locus in families UW50, UW48, UW36, and UW41. Mutations in CC2D2A are indicated by
asterisks and known carriers are marked */þ.
(F) Affected cousins in family UW50 share a haplotype of 242 consecutive homozygous SNPs (boxes) between SNP_A-1651302 and
SNP_A-1718863 (9.6 Mb).
(G) Affected individuals in Saudi Arabian families UW36 and UW48 share a region of homozygosity (larger boxes) and a haplotype of
62 consecutive homozygous SNPs between SNP_A-1714400 and SNP_A-1738845 (2.3 Mb, smaller boxes). Unaffected siblings in UW48
are heterozygous in this region.
(H) The affected individual in family UW41 has a region of homozygosity between the 4p-terminus and D4S419. Note that only markers
demarcating the regions of homozygosity and/or shared haplotypes are shown.Mutation Detection
The 2.3 Mb shared haplotype in families UW36 and UW48
encompasses 14 genes (Figure 2A). We sequenced the
coding regions and exon-intron boundaries of 13 of these
genes in all four families, detecting two homozygous mis-
sense mutations (c.3364C / T p.P1122S; c.4582C / T
p.R1528C) and one homozygous nonsense mutation
(c.2848C/ T p.R950X) in CC2D2A (Table 1 and Figure 3).
As expected from the shared haplotype, we found that the
two affected individuals in families UW36 and UW48 carry
the same mutation (p.P1122S). P1122 is conserved across
all species with related genes encoding this C2 domain,
including all animals and protists, but not plants or fungi.
R1528 is conserved in all vertebrates except pufferﬁsh.
Both missense mutations are predicted to be deleterious
by SIFT and PolyPhen.26,27 Sequence changes in the other562 The American Journal of Human Genetics 83, 559–571, Novemb12 genes within the interval were either known SNPs or
noncoding (not shown).
We then sequenced all CC2D2A exons in families that
could not be excluded by segregation analysis by using
fourmicrosatellitemarkers at 4p15 (Figure 4).We identiﬁed
compound heterozygous mutations in two families and
a single frameshiftmutation in a third nonconsanguineous
family (Table 1 and Figure 3), yielding seven different
CC2D2Amutations in 6 out of 70 JSRD families ascertained
by theMTS5other ﬁndings. A second cohort of 40 consan-
guineous JSRD families with renal disease was similarly
evaluated, yielding one homozygous mutation (p.L1551P)
in family F871, for a total prevalence of 7/110 (6%). The
L1551P change is also predicted to be possibly damaging
by Polyphen and tolerated by SIFT; however, this leucine
is evolutionarily conserved as far as opossum, and prolineer 7, 2008
Figure 2. CC2D2A Locus, Gene, Predicted Protein, and Expression
(A) Map of chromosome 4p15 locus with the regions of homozygosity in affected members of families UW36, UW48, and UW50 indicated
by horizontal lines. The genes within this interval are indicated by arrows.
(B) 37 predicted CC2D2A exons based on the UCSC genome browser. The position of the homozygous nonsense mutation in exon 23
(c.2848C/ T p.R950X) is marked with an 3. Note that exon 29a (asterisk) is not included in the RefSeq gene sequence, but is found
in at least two spliced ESTs and is highly conserved.
(C) The CC2D2A gene encodes a protein with three predicted coiled-coil domains (cylinders), as well as a single C2 domain (pentagon).
Missense mutations (gray arrows) were present in the C2 domain and the highly conserved C-terminal region (broken bar), whereas
protein-truncating mutations (black arrows) precede the C2 domain.
(D) Phylogenetic tree of the CC2D2A C2 domain reveals orthologs in diverse species and a CC2D2B paralog that is restricted to mammals.
(E) RT-PCR analysis of CC2D2A, CC2D2B, and RPGRIP1L expression in adult and fetal tissues. The HPRT (hypoxanthine phosphoribosyl-
transferase) gene was used as a template control.is not present in any species. All mutations segregated as
expected for autosomal-recessive inheritance, and the
missense mutations were absent from >210 control
chromosomes.The AmericaCC2D2A Mutations in Other Ciliopathies
We have shown recently that MKS genes contribute both
primary loci and second site modifying alleles to the path-
ogenicity of BBS.20 We therefore hypothesized that genesn Journal of Human Genetics 83, 559–571, November 7, 2008 563
Table 1. Mutations and Phenotypes in Subjects with CC2D2A Mutations
Affected
Individual Mutation(s) Age (yr) MRI/CT
Abnormal Eye
Movements
Retinal
Dystrophy Coloboma
Renal
Disease
Liver
Fibrosis Polydactyly Encephalocele
UW36-IV:4 p.P1122S/p.P1122S 1 MTS - -a - - - - -
UW46-II:1 p.V1097FfsX1/unknown 14 MTS þ - - - - - -
UW46-II:2 p.V1097FfsX1/unknown 17 MTS þ - - - - - -
UW47-II:1 p.R1019X/p.Q1096H 14 MTS þ - - - - - -
UW41-IV:1 p.R950X/p.R950X 4 MTS þ þb - - - - -
F871-II:1 p.L1551P/p.L1551P 8 VH þ - - þ - - -
UW50-VI:1 p.R1528C/p.R1528C 4 MTS/ACC - - - - - - þ
UW50-VI:3 p.R1528C/p.R1528C 7 MTS - - - - - - þc
UW48-IV:7 p.P1122S/p.P1122S 2.5 MTS þ þ - Abnormal
RUS
Mild
HSM
- -
UW49-II:1 p.V1097FfsX1/p.R1528C 22 VH/ACC/HC þ - þ þd þe - -
Affected individuals exhibit a spectrum of phenoptypes from isolated Joubert syndrome to COACH syndrome. MRI, magnetic resonance imaging; CT, com-
puted tomography scan; MTS, molar tooth sign; VH, cerebellar vermis hypoplasia; ACC, agenesis of the corpus callosum; RUS, renal ultrasound; HSM, hep-
atosplenomegaly; HC, hydrocephalus. Minus sign indicates no overt signs of phenotype unless otherwise indicated.
a Normal electroretinogram (ERG).
b Flat ERG.
c In a fetal sibling.
d Mildly increased creatinine and upper normal renal echogenicity, no renal biopsy.
e Chronic inflammation and fibrosis of the portal triads, intact sinuses and central veins, required liver transplant at 10 years of age.contributing to JSRD may also be involved in the manifes-
tation of the BBS phenotype. To explore this possibility, we
sequenced CC2D2A in 96 BBS patients preselected for hav-
ing mutations in zero or one known causative ciliopathy
locus. We detected one novel sequence variant, encoding
a heterozygous K478E amino acid change in a European
BBS family. Importantly, this variant is highly conserved
as far as stickleback and predicted to be nontolerated by
SIFT. Consistent with a potential modifying, but not
causal, role in ciliary disease, we detected this variant in
one of 192 ethnically matched control chromosomes;
further investigations will be required to ascertain the
potential effect of this allele on CC2D2A function. Overall,
the paucity of novel variants identiﬁed in BBS patients sug-
gests that CC2D2A is not a major contributor to BBS; how-
ever, screening of a larger or more ethnically diverse cohort
will be necessary to test this possibility exhaustively.
In parallel, we also evaluated the potential role of
CC2D2A in isolated nephronophthisis. By using homozy-
gosity mapping, we excluded the 4p15 locus in 86 of 90
consanguineous families via a recessive model. In the
four families that could not be excluded, we did not iden-
tify any CC2D2A mutations. These results indicate that
CC2D2Amutations are not a major cause of isolated neph-
ronophthisis.
Gene/Protein Structure
The 38 exonCC2D2A gene encodes a predicted 1620 amino
acid product with coiled-coil and C2 domains (Figures 2B
and 2C) described by Noor et al. and Tallila et al.22,23 Tallila
et al.23 also reported an additional predicted exon between
exons 29 and 30 that is not in the reference sequence
(NM_001080522), whose presence we conﬁrmed in multi-
ple tissues via RT-PCR (not shown). The nonsense and
frameshift mutations in JSRD patients precede the C2564 The American Journal of Human Genetics 83, 559–571, Novembdomain and are likely to trigger nonsense-mediated decay,
whereas the missense mutations occur in the C2 domain
and C-terminal region, supporting a functional role for
these parts of the protein (Figure 2C).
A human paralog (CC2D2B) is present on chromosome
10q23.33. Ensembl predicts a 322 amino acid CC2D2B
product that corresponds to NP_001001732 and shares
homology with the C-terminal region of CC2D2A; how-
ever, ESTs mapping to chromosome 10q23.33, comparison
of the human genomic sequence to other mammals, and
gene-prediction programs (reviewed in Brent28) reveal
a 1341 amino acid predicted protein with 33% identity/
46% similarity to CC2D2A (Figure S1). The C2 domains of
CC2D2A and CC2D2B are 42% identical and 55% similar,
whereas the C-terminal regions are 45% identical and
60% similar. CC2D2A orthologs are found in all vertebrates
and in sea urchin, jellyﬁsh, and insects, whereas CC2D2B
orthologs are found only in mammals, implicating
CC2D2B in processes restricted to this class (Figure 2D).
Interestingly, the C-terminal region of both proteins is
distantly related to the CEP76 protein, a component of
the centrosome (Figure S2).29
Human Phenotype
Weobserved a spectrumof phenotypes in our cohort (Table
1). Subject UW49-II:1 has chorioretinal coloboma, renal,
and liver disease (COACH phenotype). Liver biopsy dis-
played ‘‘chronic inﬂammation and ﬁbrosis of the portal tri-
ads, intact sinuses, and central veins’’ and required living-
related donor liver transplantation at 10 years of age. Her
creatinine has been mildly elevated and her ‘‘renal echoge-
nicitywas in theupper limitofnormal’’ on renalultrasound,
but she has not had a renal biopsy. Subject UW48-IV:7 may
also have the COACH phenotype, but details of an abnor-
mal renal ultrasound and mild hepatosplenomegaly areer 7, 2008
Figure 3. Sequence Tracings of CC2D2A Mutations
Numerical designations are based on NM_001080522.1 with the addition of exon 29a from genomic sequence (see Figure 2).notavailable. SubjectsUW48-IV:7andUW41-IV:1alsohave
evidence of retinal dystrophy. Subjects UW50-VI:1 and
UW50-VI:3 have encephaloceles similar to patients with
MKS, whereas subjects UW50-VI:1 and UW49-II:1 have
agenesis of the corpus callosum seen in a subset of individ-
uals with JSRD. Affected individuals in UW36 and UW46
did not exhibit retinal, renal, or liver disease; however,
UW36 was only 1 year old at last follow-up, and we found
only a single CC2D2A mutation (p.V1097FfsX1) in UW46.
Noaffected individualshadpolydactyly.Althougholfactory
dysfunction has been observed in BBS,30 it was not noted
clinically in subjects with CC2D2A mutations, none of
whom were formally tested for anosmia. After identifying
CC2D2A mutations in subjects with JSRD, we reviewed
the brain MRI images from two of the affected individuals
with homozygous CC2D2A mutations described by Noor
et al.,22 andwe identiﬁed the characteristic imaging features
of Joubert syndrome in both subjects (one shown in Figures
4E and4E0). No overt ﬁndings of liver or kidney diseasewere
identiﬁed in this family.
Expression
CC2D2A transcript could not be detected via human mul-
tiple-tissue northern blots (not shown); however, we wereThe Americaable to detect transcript in all adult and fetal tissues tested
via RT-PCR (Figure 2E). Interestingly, expression was
substantially higher in fetal brain than in adult brain,
whichmay indicate an increased requirement in this tissue
during development. High levels of expression were also
detected in retina and kidney, commonly affected in JSRD.
Colocalization of CC2D2A with CEP290
at the Basal Body
To investigate whether CC2D2A and CEP290 function in
the same location, we transfected hTert-RPE1 cells with
eCFP-tagged full-length CC2D2A. As described previously
in COS-7 cells,22 eCFP-CC2D2A is seen in the cytoplasm;
however, after inducing cilia formation by serum starva-
tion, eCFP-CC2D2A also localizes to the base of the cilia,
as indicated by costaining with the anti-polyglutaminated
tubulin antibody GT-335 (Figures 5A–5C). Costaining with
CEP290 antibody3 demonstrates that recombinant
CC2D2A at the basal body colocalizes with endogenous
CEP290 (Figures 5D–5F).
Physical Interaction between CC2D2A and CEP290
Based on the hypothesis that CC2D2A might function in
the primary cilium/basal body protein network,31 wen Journal of Human Genetics 83, 559–571, November 7, 2008 565
Figure 4. Segregation Analysis and MRI Images in Additional Families with CC2D2A Mutations
(A–E) Sagittal (A–E) and axial (A0–E0) MRI images of subjects UW46 II:1 (A, A0), UW46 II:2 (B, B0), UW47 II:1 (C, C0), UW41 II:1 (D, D0),
and Noor et al. subject 3622 (E, E0), revealing cerebellar vermis hypoplasia (arrowhead) and thick, horizontally oriented superior cerebellar
peduncles (arrows). Mildly prominent temporal horns are bracketed in several axial images, consistent with mild ventriculomegaly. The
cerebellar hemispheres in subject 36 appear atrophic (E0). (A–D, B0) T1-weighted images; (E) a T2/FLAIR-weighted image; (A0, C0–E0)
T2-weighted images.
(F–H) Chromosome 4p15 could not be excluded by segregation of microsatellite markers in families UW46, UW47, and UW49.
(I) Pedigree for consanguineous family F871.assessed 23 ciliopathy-associated proteins (including
CEP290, RPGRIP1L, RPGRIP1, RPGR [MIM 312610], and
BBS1-12 [MIM 209900]) for interaction with CC2D2A via
a yeast two-hybrid mating assay (Table S2). These proteins
were chosen on the basis of their involvement in a ciliop-
athy-associated protein network.31 Of all combinations
tested, only CEP290 was found to interact with CC2D2A
(Figure 5G) and the interaction was conﬁrmed by a GST
pull-down assay (Figures 5H–5J). The interaction is speciﬁc
for the N-terminal 998 amino acids of CC2D2A and an
internal fragment of CEP290 (amino acids 703–1130)
containing coiled-coil domains 4-6.
Modeling Loss of cc2d2a Function in Zebraﬁsh
In a screen for mutations modifying aminoglycoside-
induced mechanosensory hair cell damage, Owens et al.
identiﬁed a nonsense mutation (sentinel [snl]) that lies
N-terminal to the C2 domain in the sole zebraﬁsh ortholog
of CC2D2A (cc2d2a).32 The Cc2d2a protein is more closely
related to CC2D2A (60% identical, 74% similar) than566 The American Journal of Human Genetics 83, 559–571, NovemCC2D2B (34% identical, 48% similar; Figure S1), with
higher homology in the C2 domain and C-terminal
region. We found that cc2d2a transcript is reduced sub-
stantially in snl/snl ﬁsh versus their wild-type and hetero-
zygous siblings (Figure 6A), presumably because of
nonsense-mediated decay. To further explore CC2D2A
function and develop a zebraﬁsh model for JSRD, we eval-
uated snl/snl ﬁsh for phenotypes reminiscent of JSRD and
ciliary dysfunction including pronephric cysts, laterality
defects, brain malformation, as well as defects in cilium
number and morphology.33 Although other obvious de-
fects were not observed, 33% of the snl/snl ﬁsh (conﬁrmed
by genotyping) exhibited pronephric cysts by 6 days post-
fertilization (dpf) compared to 0% of their wild-type and
heterozygous siblings (Figures 6B and 6E). We used anti-
acetylated tubulin antibody34 to visualize motile cilia in
the lumen of pronephric tubule and caudal region of the
central canal. We were unable to discern any overt differ-
ences with respect to cilium number or morphology
between snl/snl ﬁsh and their wild-type and heterozygousber 7, 2008
Figure 5. CC2D2A and CEP290 Colocalize at the Basal Body and Interact in Yeast Two-Hybrid Assay and GST Pull-Down
(A–C) Colocalization of eCFP-tagged CC2D2A (green) and ciliary marker GT-335, a mouse monoclonal antibody against polyglutaminated
tubulin (red), in cultured retinal pigment epithelial cells (hTERT-RPE1). In addition to the specific localization to the basal body (arrows),
eCFP-CC2D2A is also in the cytoplasm, possibly because of overexpression ([A and C], green).
(D–F) Colocalization of eCFP-tagged CC2D2A (green) and CEP290 (red) to the basal bodies (arrows) of cultured hTERT-RPE1 cells.
(G) CC2D2A interaction with CEP290 in a yeast two-hybrid assay. Bait plasmids expressing different fragments of CC2D2A as binding do-
main (BD)-fusion proteins were cotransformed in the PJ69-4 alpha yeast strain together with prey plasmids expressing CEP290 fragment
CC4-6 (aa 703–1130) as activation domain (AD)-fusion proteins. Plates lacking the amino acids Leu and Trp (-LW, top) selected for
cotransformants, whereas additional omission of His and Ade from the plates (-LWHA, middle) selected for activation of the cognate
reporter genes. A blue color in the b-galactosidase filter lift assay (bottom) indicates activation of the LacZ reporter gene. All reporter
genes were only activated by the interaction of the CC2D2A fragment Nterm-C2 (aa 1–998). The rightmost column (þ) represents a
positive control of the wild-type AD and BD domains.
(H–J) GST pull-down analysis of recombinant CC2D2A and CEP290 fragments.
(H) Expression of GST-alone (~26 kDa, lane 1) and GST-CEP290CC4-6 (amino acids 703–1030, which encode coiled-coil domains 4-6,
~78 kDa, lane 2). The Simply Blue-stained gel shows 10% of the input that was used in the GST pull-down experiment.
(I) Expression of 3xFlag-tagged CC2D2ANterm-C2 (amino acids 1–998, which encode the N-terminal domain until the C2 domain; lanes 1 and
2). The blot shows 10% of the input that was used in the GST pull-down.
(J) GST-CEP290CC4-6 specifically pulls down 3xFlag-CC2D2ANterm-C2 (band at 150 kDa, lane 2), whereas GST alone does not (lane 1).siblings at 48 hpf, although subtle differences could not be
excluded.
Functional Interaction with CEP290
To assess the functional signiﬁcance of the CC2D2A-
CEP290 physical interaction, we evaluated the effects of
decreased cep290 function in the snl/snl background. Sayer
et al. found that knockdownof cep290 function inzebraﬁsh
via cep290morpholinos resulted in pronephric cyst forma-
tion,5 so we titrated splice blocking (cep290splMO) and
translation blocking (cep290atgMO) morpholinos to give
a low prevalence of pronephric cysts in wild-type ﬁsh. We
then injected offspring of a snl/þ_ 3 snl/þ\ cross and ob-The Americserved a striking exacerbation of the cyst phenotype in in-
jected snl/snl ﬁsh compared to their injected siblings (snl/þ
and þ/þ) and uninjected snl/snl ﬁsh (Figures 6B–6E). The
cysts were larger, more prevalent, and evident 2 days earlier
in the injected snl/snl ﬁsh, suggesting the cooperative
action of CC2D2A and CEP290 in the pronephros. Cilia
in injected snl/snl ﬁsh also appeared similar inmorphology
and number compared to wild-type.
Discussion
Coding mutations in CC2D2A account for 6/70 families
(9%) in a cohort of JSRD families with consanguinity oran Journal of Human Genetics 83, 559–571, November 7, 2008 567
Figure 6. Zebrafish sentinel Phenotype and Synergistic Genetic Interaction with cep290
(A) cc2d2a expression is greatly reduced in snl/snl fish versus their snl/þ and þ/þ siblings. The odc1 gene was used as a template control.
(B and C) Tail and pronephros phenotype in snl/snl fish (B) and snl/snl fish injected with cep290splMO (C) at 4 dpf. snl/snl fish (B) have
a sinusoidal-shaped tail and develop pronephric cysts (arrows) starting at 4 dpf, whereas snl/snl fish injected with cep290splMO (C)
develop larger pronephric cysts starting at 2 dpf. Some of these fish also develop pericardial effusion (asterisk).
(D) AB wild-type fish for comparison.
(E) Frequency of pronephric cysts in snl/snl fish and their wild-type siblings (snl/þ and þ/þ) with and without cep290splMO. Brackets
indicate 95% confidence intervals (p< 0.0001 for comparison between snl/snl fish and their wild-type siblings [snl/þ and þ/þ] injected
with either CEP290 morpholino; chi-square test). dpf, days postfertilization; cep290splMO, cep290 splice-blocking morpholino.more than one offspring, makingCC2D2A amajor contrib-
utor to JSRD, similar to AHI1 and CEP290.5,35 We observed
a broad spectrum of phenotypes in our subjects with
CC2D2Amutations, including uncomplicated Joubert syn-
drome, the COACH subtype of JSRD,2 and individuals with568 The American Journal of Human Genetics 83, 559–571, Novembfeatures overlapping with MKS (encephalocele and liver
disease). Noor et al. reported a splice-site mutation segre-
gating in a family now shown to have JSRD rather than
autosomal-recessive mental retardation and retinitis pig-
mentosa.22 In fetuses with MKS from a Finnish cohort,er 7, 2008
Tallila et al. reported a single homozygous splice-site muta-
tion that affects splicing and truncates CC2D2A earlier in
the protein than any of the mutations in our series.23
This offers a suggestion of genotype-phenotype correla-
tion; however, the mutation predicted to be the most se-
vere in our cohort (p.R950X prior to the C2 domain in fam-
ily UW41) is associated with a relatively mild phenotype
(no renal or liver disease), indicating that other factors,
such as extragenic modiﬁers, are playing a role as they do
in other ciliopathies.36–38 In addition, subjects UW50-VI:1
and UW50-VI:3, despite having the same mutation, are
discordant for agenesis of the corpus callosum. Subjects
UW36-IV:4 and UW48-IV:7 also share the same mutation
(P1122S) but are discordant for retinal dystrophy and
potentially, for renal and liver disease. These observations
provide support for the idea that JSRD and MKS are allelic
disorders and that the liver ﬁbrosis phenotype in COACH
syndrome represents the milder end of the spectrum from
the more severe ductal plate malformation seen in MKS.39
The pronephric cyst phenotype in sentinel ﬁsh is similar
to that seen in other zebraﬁsh with cilium dysfunction33
and partially recapitulates the human JSRD phenotype.
In contrast to the absence of primary cilia in cultured ﬁbro-
blasts from fetuses with MKS reported by Tallila et al.,23 we
did not observe defects in the pronephric cilia of homozy-
gous snl ﬁsh. It may be that the zebraﬁsh mutation is less
severe than the human mutation; however, the two muta-
tions are both predicted to truncate the protein just after
the predicted coiled-coil domains and before the C2
domain. Alternatively, cc2d2a function may be required
for formation/maintenance of human ﬁbroblast cilia but
not zebraﬁsh pronephros cilia. The connection between
JSRD in humans and aminoglycoside resistance of mecha-
nosensory hair cells in zebraﬁsh is mysterious. Hearing loss
is not a typical feature of JSRD and given the rarity of JSRD
patients, demonstrating resistance to aminoglycoside-
induced hearing loss in humans with JSRD is not feasable.
As yet, an in vitro assay for aminoglycoside resistance in
easily available human tissues has not been developed;
however, this could be the subject of future work to con-
nect the human and zebraﬁsh phenotypes and explore
the mechanisms underlying JSRD and aminoglycoside
resistance. The relationship between ciliary dysfunction
and aminoglycoside resistance is also not obvious. Al-
though zebraﬁsh hair cells possess a microtubule-based
kinocilium at their apical surface, this structure does not
appear to be disrupted and mechanotransduction appears
normal in sentinel mutants.32 The ﬁrst detectable defect
in zebraﬁsh hair cells exposed to neomycin is a loss of
mitochondrial potential and mitochondrial swelling.40 It
remains to be determined whether CC2D2A mutations
block the toxic effect of aminoglycosides on themitochon-
dria, decrease the sensitivity of hair cells to mitochondrial
dysfunction/energy starvation, or prevent hair cell damage
by other mechanisms.
Our data suggest a functional role for CC2D2A at the
basal body, closely associated with CEP290. We showThe Americathat recombinant eCFP-CC2D2A colocalizes with CEP290
to the basal body in cultured ciliated cells, and the two pro-
teins may directly interact, because the recombinant pro-
teins are able to physically bind. Ideally, these experiments
will need to be conﬁrmed on endogenous proteins via
antibodies to CC2D2A, especially because GST pull-down
assays showed afﬁnity between recombinant CC2D2A
and other higher-molecular-weight proteins (results not
shown). A variety of evidence provides additional support
for the role of CC2D2A at the basal body. CC2D2A encodes
a coiled-coil and C2 calcium/lipid binding domain protein
included in the cilium/basal body proteome.41 Despite
a lack of direct sequence homology, CC2D2A has a strik-
ingly similar overall structure to RPGRIP1L and RPGRIP1,
two basal body proteins defective in JSRD/MKS and
LCA.3,4,21 The loss-of-function phenotype for CC2D2A
overlaps with other disorders of ciliary function in humans
and zebraﬁsh. Tallila et al. found that cilia were absent
from ﬁbroblasts cultured from fetuses with an early trun-
cating mutation in CC2D2A.23 The C. elegans (K07G5.3)
and D. melanogaster (CG18631) CC2D2A orthologs each
have an xbox sequence in their promoter region, predicted
to bind DAF-19, a transcription factor involved in regula-
tion of a broad spectrum of ciliary genes.42–44 The
CC2D2A C-terminal region is also similar to CEP76, an-
other widely conserved C2 domain protein that is present
in the centrosome and required in the cilium.19,29 Further-
more, CC2D2A was identiﬁed in a screen for proteins that
interact with calmodulin,45 raising the possibility that
CC2D2A participates in calcium-dependent signaling
pathways and the network of proteins required for retinal
photoreceptor development/function, including CEP290,
RPGR, RPGRIP1, RPGRIP1L, NPHP4 (MIM 607215), and
NPHP5 (MIM 609237).46
In conclusion, we demonstrate that CC2D2A is responsi-
ble for a substantive proportion of JSRD including cases
with the distinctive COACH subtype that likely represents
a transitional phenotype between JSRD and MKS. Further-
more, CC2D2A functions in close association with CEP290
and provides a model for studying the impact of an extra-
genic modiﬁer (i.e., decreased CEP290 function) on the
phenotypes resulting from mutations in a causal gene
(CC2D2A).
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